Identification | Back Directory | [Name]
Syntelin | [CAS]
438481-33-5 | [Synonyms]
Syntelin 2-((5-(((4-amino-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-2-yl)thio)methyl)-4-phenyl-4H-1,2,4-triazol-3-yl)thio)acetic acid 2-[[5-[(4-amino-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-2-yl)sulfanylmethyl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetic acid | [Molecular Formula]
C21H20N6O2S3 | [MDL Number]
MFCD03147450 | [MOL File]
438481-33-5.mol | [Molecular Weight]
484.62 |
Hazard Information | Back Directory | [Description]
Syntelin is a selectively CENP-E inhibitor. Syntelin inhibited CENP-E motility in a dose-dependent manner with an IC50 value of 160 nM. Among an extensive list of mitotic kinesins examined, syntelin was found to be highly selective for CENP-E. Syntelin binds to different sites from those of GSK923295, a recently identified CENP-E ATPase inhibitor, as syntelin inhibits CENP-E mutants resistant to GSK923295 in a manner indistinguishable from that of wild type motor. Syntelin represents a novel class of CENP-E motor inhibitor. |
|
Company Name: |
PHARMEKS Ltd.
|
Tel: |
+7 (495) 702-9648 |
Website: |
www.pharmeks.com |
Company Name: |
OTAVA chemicals
|
Tel: |
416 305 9979 (Canada) |
Website: |
www.otavachemicals.com |
|